UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062828
Receipt number R000071890
Scientific Title Association Between AI-Estimated Atrial Fibrillation Risk and Cardiac Functional and Structural Parameters: A Prospective Observational Study Using the FCP-9900Ai
Date of disclosure of the study information 2026/09/10
Last modified on 2026/09/04 20:10:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association Between AI-Estimated Atrial Fibrillation Risk and Cardiac Functional and Structural Parameters: A Prospective Observational Study Using the FCP-9900Ai

Acronym

Association Between AI-Estimated Atrial Fibrillation Risk and Cardiac Functional and Structural Parameters: A Prospective Observational Study Using the FCP-9900Ai

Scientific Title

Association Between AI-Estimated Atrial Fibrillation Risk and Cardiac Functional and Structural Parameters: A Prospective Observational Study Using the FCP-9900Ai

Scientific Title:Acronym

Association Between AI-Estimated Atrial Fibrillation Risk and Cardiac Functional and Structural Parameters: A Prospective Observational Study Using the FCP-9900Ai

Region

Japan


Condition

Condition

Patients undergoing electrocardiography and echocardiography who are in sinus rhythm at the time of examination

Classification by specialty

Cardiology Laboratory medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the association between AI-detected latent atrial fibrillation risk and cardiac function and structure by stratifying patients according to the risk grade detected by the FCP-9900Ai and comparing echocardiographic parameters among the groups.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Association Between AI-Derived Atrial Fibrillation Risk Scores and Echocardiographic Parameters
Left atrial diameter (LAD) and left atrial volume index (LAVI)
Left ventricular diastolic function parameters (E/A ratio, e', and E/e' ratio)
Left ventricular ejection fraction (LVEF)
Left atrial strain

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing electrocardiography and echocardiography who are in sinus rhythm at the time of examination

Key exclusion criteria

(1) Patients receiving antiarrhythmic drugs
(2) Patients who have undergone catheter ablation
(3) Patients with a history of open-heart surgery
(4) Patients with an implanted pacemaker
(5) Patients with a history of cardioembolic stroke
(6) Patients with mitral stenosis
(7) Patients who have undergone prosthetic valve replacement
(8) Patients in whom echocardiographic findings cannot be obtained due to poor image quality
(9) Patients with atrial fibrillation or atrial flutter at the time of examination

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Sendo
Middle name
Last name Syo

Organization

Kobe University Hospital

Division name

Department of Clinical Laboratory

Zip code

6500017

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan

TEL

078-382-6314

Email

sho1000d@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Sendo
Middle name
Last name Syo

Organization

Kobe University Hospital

Division name

Department of Clinical Laboratory

Zip code

6500017

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan

TEL

078-382-6314

Homepage URL


Email

sho1000d@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University Hospital

Institute

Department

Personal name



Funding Source

Organization

Fukuda Denshi Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan

Tel

078-382-6314

Email

sho1000d@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 30 Day

Date of IRB


Anticipated trial start date

2026 Year 10 Month 01 Day

Last follow-up date

2027 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We will analyze patients who underwent clinically indicated electrocardiography and echocardiography at our institution, including patients with left ventricular hypertrophy, such as those with cardiac amyloidosis, Fabry disease, or hypertrophic cardiomyopathy, as well as patients in whom assessment of left ventricular diastolic function is difficult.


Management information

Registered date

2026 Year 09 Month 04 Day

Last modified on

2026 Year 09 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071890